Patent | Date |
---|
Method of treating insomnia with halogenated pyrazolo[1,5-a]pyrimidines Grant 10,072,000 - Anglada , et al. September 11, 2 | 2018-09-11 |
Halogenated Pyrazolo[1,5-a]pyrimidines, Processes, Uses, Compositions And Intermediates App 20160368912 - Anglada; Luis ;   et al. | 2016-12-22 |
Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates App 20130331401 - Anglada; Luis ;   et al. | 2013-12-12 |
Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates App 20130331610 - Anglada; Luis ;   et al. | 2013-12-12 |
Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates Grant 8,530,482 - Anglada , et al. September 10, 2 | 2013-09-10 |
1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-- dihydro-3-quinolinecarboxylic acid salts Grant 8,507,684 - Palomer , et al. August 13, 2 | 2013-08-13 |
Process For Preparing 4-nitro-oxy-methyl-benzoic Acid App 20130131378 - Anglada; Luis ;   et al. | 2013-05-23 |
1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-- Dihydro-3-quinolinecarboxylic Acid Salts App 20130040989 - Palomer; Albert ;   et al. | 2013-02-14 |
Amorphous form of N-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-ph- enyl}-N-methyl-acetamide Grant 8,338,436 - Anglada , et al. December 25, 2 | 2012-12-25 |
Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-ph- enyl}-N-methyl-acetamide Grant 8,273,753 - Anglada , et al. September 25, 2 | 2012-09-25 |
Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions Grant 8,158,632 - Anglada , et al. April 17, 2 | 2012-04-17 |
Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide Grant 8,039,476 - Anglada , et al. October 18, 2 | 2011-10-18 |
Polymorph B of N--N-methyl-acetamide App 20110224234 - Anglada; Luis ;   et al. | 2011-09-15 |
Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound Grant 8,008,486 - Anglada , et al. August 30, 2 | 2011-08-30 |
N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto Grant 7,947,688 - Anglada , et al. May 24, 2 | 2011-05-24 |
Amorphous Form Of An Anti-inflammatory Compound App 20100261691 - Anglada; Luis ;   et al. | 2010-10-14 |
Amorphous Form Of N--n-methyl-acetamide App 20100137339 - Anglada; Luis ;   et al. | 2010-06-03 |
Polymorph B Of N--n-methyl-acetamide App 20100087451 - Anglada; Luis ;   et al. | 2010-04-08 |
Process For The Manufacture Of A Crystalline Pyrazolo[1,5-a]pyrimidine Compound App 20100048896 - Anglada; Luis ;   et al. | 2010-02-25 |
Pyrazolo[1,5-a]pyrimidines, Processes, Uses And Compositions App 20090264448 - Anglada; Luis ;   et al. | 2009-10-22 |
Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates App 20090111848 - Anglada; Luis ;   et al. | 2009-04-30 |
7-Substituted 3-nitro-pyrazo[1,5-a] pyrimidines App 20070043064 - Anglada; Luis ;   et al. | 2007-02-22 |
N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto App 20060270690 - Anglada; Luis ;   et al. | 2006-11-30 |